President Donald Trump’s team is rejecting former President Biden's plan to cover weight loss drugs like Wegovy and Zepbound for older Americans through Medicare. The Centers for Medicare and Medicaid Services said Friday it will not finalize a rule proposed by the Biden administration to cover the drugs,

The Centers for Medicare and Medicaid Services said it would not cover the medications under Medicare’s Part D coverage.

The Trump administration will not finalize a Biden-era plan to require coverage of anti-obesity medications in Medicare and Medicaid. In a rule finalized Friday afternoon, the Centers for Medicare and Medicaid Services stated it does not intend to continue with the Biden proposal,